The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

EndNote Style
Superior vena cava syndrome
Superior vena cava syndrome is the general name for the symptoms and presentation due to acute obstruction or occlusion of the superior vena cava flow. It usually develops secondary to underlying malignancies and is a life-threatening oncologic emergency. In this review, the current clinical approach to superior vena cava syndrome, including the etiologic considerations, investigations that should be planned, diagnosis, and treatment algorithms, is reviewed.

1. Friedman T, Quencer KB, Kishore SA, Winokur RS, Madoff DC.Malignant venous obstruction: superior vena cava syndrome andbeyond. Semin Interv Radiol. 2017;34(04):398-408.
2. Rice TW, Rodriguez RM, Light RW. The superior vena cava syndrome:clinical characteristics and evolving etiology. Medicine. 2006;85(1):37-42.
3. Lin FY, Devereux RB, Roman MJ, et al. The right sided great vesselsby cardiac multidetector computed tomography: normative referencevalues among healthy adults free of cardiopulmonary disease,hypertension, and obesity. Acad Radiol. 2009;16(8):981-987.
4. Patriarcheas V, Grammoustianou M, Ptohis N, et al. Malignant superiorvena cava syndrome: state of the art. Cureus. 2022;14(1):e20924.
5. Rabinstein AA, Wijdicks EF. Fatal brain swelling due to superior venacava syndrome . Neurocrit Care. 2009;10(1):91-92. doi: 10.1007/s12028-008-9129-0
6. Perles Z, Nir A, Gavri S, et al. Prevalence of persistent superior venacava and association with congenital heart anomalies. Am J Cardiol.2013;112(8):1214-1218.
7. Wilson LD, Detterbeck FC, Yahalom J. Clinical practice. Superior venacava syndrome with malignant causes. N Engl J Med. 2007;356(18):1862-1869.
8. Bardet J, Fabre D, Brenot P, Watkins C, Fadel E. Kissing stents forsuperior vena cava syndrome due to mediastinal fibrosis. Open JCardiovasc Surg. 2018;10:1179065218771900.
9. Rizvi AZ, Kalra M, Bjarnason H, Bower TC, Schleck C, Gloviczki P.Benign superior vena cava syndrome: stenting is now the first line oftreatment. J Vasc Surg. 2008;47(2):372-380.
10. Ellison MB, Statler A, Henrickson RE, et al. Iatrogenic superiorvena cava syndrome after cardiopulmonary bypass diagnosedby intraoperative echocardiography. Case Rep Anesthesiol.2020;2020:8813065. doi: 10.1155/2020/8813065
11. Chee CE, Bjarnason H, Prasad A. Superior vena cava syndrome: anincreasingly frequent complication of cardiac procedures. Nat ClinPract Cardiovasc Med. 2007;4(4):226-230.
12. Cheng S. Superior vena cava syndrome: a contemporary review of ahistoric disease. Cardiol Rev. 2009;17(1):16-23.
13. Yu JB, Wilson LD, Detterbeck FC. Superior vena cava syndrome--aproposed classification system and algorithm for management. J ThoracOncol. 2008;3(8):811-814. doi: 10.1097/JTO.0b013e3181804791
14. Loudin M, Anderson S, Schlansky B. Bleeding ‘downhill’ esophagealvarices associated with benign superior vena cava obstruction: casereport and literature review. BMC Gastroenterol. 2016;16(1):134.
15. Sonavane SK, Milner DM, Singh SP, Abdel Aal AK, Shahir KS,Chaturvedi A. Comprehensive imaging review of the superior venacava. Radiograph. 2015;35(7):1873-1892. doi: 10.1148/rg.2015150056
16. Stanford W, Doty DB. The role of venography and surgery in themanagement of patients with superior vena cava obstruction. AnnThorac Surg. 1986;41(2):158-163.
17. Gülhan M, Ogan N. Vena Kava Süperior Sendromu. In: Gülhan M,Yılmaz Ü, eds. Akciğer Kanserinde Destek Tedavisi. TÜSAD: 2016:144-154.
18. Azizi AH, Shafi I, Shah N, et al. Superior vena cava syndrome.Cardiovasc Interv. 2020;13(24):2896-2910. doi: 10.1016/j.jcin.2020.08.038. PMID: 33357528
19. Lanciego C, Pangua C, Chacon JI, et al. Endovascular stenting as thefirst step in the overall management of malignant superior vena cavasyndrome. Am J Roentgenol. 2009;193(2):549-558.
20. Rowell NP, Gleeson FV. Steroids, radiotherapy, chemotherapy andstents for superior vena caval obstruction in carcinoma of the bronchus:a systematic review. Clin Oncol. 2002;14(5):338-351.
21. Mose S, Stabik C, Eberlein K, Ramm U, Bottcher HD, Budischewski K.Retrospective analysis of the superior vena cava syndrome in irradiatedcancer patients. Anticanc Res. 2006;26(6C):4933-4936.
22. Lonardi F, Gioga G, Agus G, Coeli M, Campostrini F. Double-flash,large-fraction radiation therapy as palliative treatment of malignantsuperior vena cava syndrome in the elderly. Supp Care Canc.2002;10(2):156-160.
23. Kalra M, Sen I, Gloviczki P. Endovenous and operative treatment ofsuperior vena cava syndrome. Surg Clin North Am. 2018;98(2):321-335.
24. Shamimi-Noori SM, Clark TWI. Venous stents: current status andfuture directions. Tech Vasc Interv Radiol. 2018;21(2):113-116.
25. Hammer F, Becker D, Goffette P, Mathurin P. Crushed stents in benignleft brachiocephalic vein stenoses. J Vasc Surg. 2000;32(2):392-396.
26. Wilson E, Lyn E, Lynn A, Khan S. Radiological stenting provideseffective palliation in malignant central venous obstruction. ClinOncol. 2002;14(3):228-232.
Volume 2, Issue 2, 2024
Page : 47-50